Clinical Research Progress of Immune Checkpoint Inhibitors in the Treatment of 
Small Cell Lung Cancer

With the in-depth study of tumor immunity, immunotherapy represented by immune checkpoint inhibitors has made a great breakthrough in solid tumors. Small cell lung cancer (SCLC) accounts for about 15%-20% of all lung cancers, with high malignancy, early metastasis and lack of effective treatment str...

Full description

Saved in:
Bibliographic Details
Main Authors: Benlin HUANG, Yong DUAN
Format: Artigo
Language:Chinês
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2019-04-01
Series:Chinese Journal of Lung Cancer
Subjects:
Immune checkpoint inhibitors
Small cell lung cancer
PD-1
PD-L1
CTLA-4
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2019.04.07
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items